Literature DB >> 825134

Disposition of disodium cromoglycate administered in three particle sizes.

S H Curry, A J Taylor, S Evans, S Godfrey, E Zeidifard.   

Abstract

1 Disodium cromoglycate (DSCG) was administered in three particle sizes to five human subjects. 2 Urinary excretion of DSCG, as a proportion of the dose, was highest following small particles; the lower values recorded following intermediate-sized and large particles were similar. 3 DSCG deposited in the mouth was highest following large particles; the lower values recorded following intermediate-sized and small particles were similar. 4 The data were examined in relation to the recent observation that the protective effect of small particles of DSCG is dramatically superior to that of large particles.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 825134      PMCID: PMC1402577          DOI: 10.1111/j.1365-2125.1975.tb01586.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  7 in total

1.  The fate of ( 14 C)disodium cromoglycate in man.

Authors:  S R Walker; M E Evans; A J Richards; J W Paterson
Journal:  J Pharm Pharmacol       Date:  1972-07       Impact factor: 3.765

2.  Distribution and metabolism of disodium cromoglycate in rats.

Authors:  G F Moss; K M Jones; J T Ritchie; J S Cox
Journal:  Toxicol Appl Pharmacol       Date:  1970-11       Impact factor: 4.219

3.  The possible site of action of sodium cromoglycate assessed by exercise challenge.

Authors:  S Godfrey; E Zeidifard; K Brown; J H Bell
Journal:  Clin Sci Mol Med       Date:  1974-02

4.  Uptake of disodium cromoglycate in obstructive airways disease.

Authors:  M K Benson; S H Curry; G G Mills; D T Hughes
Journal:  Clin Allergy       Date:  1973-12

5.  Letter: A note on the analysis of disodium cromoglycate (Intal) in human urine.

Authors:  S H Curry; G G Mills
Journal:  J Pharm Pharmacol       Date:  1973-08       Impact factor: 3.765

6.  Plasma levels and urinary excretion of disodium cromoglycate afer inhalation by human volunteers.

Authors:  G F Moss; K M Jones; J T Ritchie; J S Cox
Journal:  Toxicol Appl Pharmacol       Date:  1971-10       Impact factor: 4.219

7.  The absorption and clearance of disodium cromoglycate from the lung in rat, rabbit, and monkey.

Authors:  G F Moss; J T Ritchie
Journal:  Toxicol Appl Pharmacol       Date:  1970-11       Impact factor: 4.219

  7 in total
  2 in total

Review 1.  Fundamental effects of particle morphology on lung delivery: predictions of Stokes' law and the particular relevance to dry powder inhaler formulation and development.

Authors:  Timothy M Crowder; Jacky A Rosati; Jeffry D Schroeter; Anthony J Hickey; Ted B Martonen
Journal:  Pharm Res       Date:  2002-03       Impact factor: 4.200

Review 2.  Cromolyn.

Authors:  B A Berman; R N Ross
Journal:  Clin Rev Allergy       Date:  1983-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.